Chelsea Counsel Co
Source: SEC Form 13F · as of Mar 2026Chelsea Counsel Co holds 19 biotech & pharma companies tracked by BioSniper, totaling $13.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$13.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 21,544 | $4.5M |
| AMGNAMGEN INC | 10,874 | $3.6M |
| ABTABBOTT LABORATORIES | 21,311 | $2.7M |
| PRMEPrime Medicine, Inc. | 227,000 | $788K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 9,360 | $463K |
| LLYELI LILLY & Co | 381 | $409K |
| MRKMerck & Co., Inc. | 3,260 | $346K |
| SNYSanofi | 1,910 | $93K |
| MCKMcKesson Corporation | 100 | $82K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 150 | $68K |
| PMPhilip Morris International Inc | 300 | $49K |
| ABBVAbbVie Inc. | 114 | $26K |
| NVONovo Nordisk A/S | 500 | $25K |
| BAXBaxter International Inc. | 1,280 | $24K |
| CORCencora Inc. | 65 | $22K |
| CTXRCitius Pharmaceuticals, Inc. | 4,626 | $4K |
| MRNAModerna, Inc. | 100 | $3K |
| GILDGILEAD SCIENCES, INC. | 4 | $491 |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1 | $331 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.